$0.282000
0.00100.36%
At Close: -
$0.289000
0.00702.48%
After Hours: Sep 20, 7:57 PM EDT
15 minutes delayed
Lyra Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lyra Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.29 | $-0.33 | 12.1 % |
Mar 2024 | 2024-04-30 | $-0.35 | $-0.26 | -34.6 % |
Dec 2023 | 2024-03-21 | $-0.22 | $-0.31 | 29.0 % |
Sep 2023 | 2023-11-07 | $-0.27 | $-0.32 | 15.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $598.00K | $350.00K | 70.9 % |
Mar 2024 | 2024-04-30 | $532.00K | $420.00K | 26.7 % |
Dec 2023 | 2024-03-21 | $146.00K | $390.00K | -62.6 % |
Sep 2023 | 2023-11-07 | $544.00K | $370.00K | 47.0 % |
Lyra Therapeutics (LYRA) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.29, which beat the estimate of $-0.33.
The Actual Revenue was $598K, which beat the estimate of $350K.
Browse earnings estimates, EPS, and revenue on all stocks.